1-3 of 3
Klaus-Michael Debatin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALL

Maren Christiane Wichert, Colin Fortner, Alexandra Niedermayer, Johanna Bender, Stefanie Enzenmüller, Klaus-Michael Debatin, Lüder Hinrich Meyer, Felix Seyfried
Journal: Blood Advances
Blood Adv (2024) 8 (23): 6035–6042.
https://doi.org/10.1182/bloodadvances.2024013194
Published: 2024
Includes: Supplemental data
Journal Articles

Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation

Juan Lázaro-Navarro, Helia Judith Pimentel-Gutiérrez, Anton Gauert, Anja I. H. Hagemann, Jassi Eisenschmid, Nicola Gökbuget, Binje Vick, Irmela Jeremias, Felix Seyfried, Lüder Hinrich Meyer, Klaus-Michael Debatin, Kathrin Richer, Miriam Bultman, Martin Neumann, Sonja Hänzelmann, Hubert Serve, Kathy Astrahantseff, Michael A. Rieger, Cornelia Eckert, Claudia D. Baldus, Lorenz Bastian
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5501–5506.
https://doi.org/10.1182/bloodadvances.2021004513
Published: 2021
Includes: Supplemental data
Journal Articles

Stem cell transplantation for osteopetrosis in patients beyond the age of 5 years

Clinical Trials & Observations
Polina Stepensky, Sigal Grisariu, Batia Avni, Irina Zaidman, Bella Shadur, Orly Elpeleg, Mehtap Sirin, Manfred Hoenig, Catharina Schuetz, Ingrid Furlan, Meinrad Beer, Stephanie von Harsdorf, Donald Bunjes, Klaus-Michael Debatin, Ansgar S. Schulz
Journal: Blood Advances
Blood Adv (2019) 3 (6): 862–868.
https://doi.org/10.1182/bloodadvances.2018025890
Published: 2019
Includes: Multimedia, Supplemental data